Sat Sep 14 11:35:45 UTC 2024: ## Investor Law Firm Files Class Action Lawsuit Against Outset Medical, Inc.

**NEW YORK, Sept. 14, 2024** – The Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit against Outset Medical, Inc. (NASDAQ: OM), alleging the company made misleading statements about its Tablo products and its business prospects.

The lawsuit, filed on behalf of investors who purchased Outset Medical securities between August 1, 2022, and August 7, 2024, claims the company failed to disclose that:

* Its Tablo products were marketed for continuous renal replacement therapy, which was not FDA-approved.
* The company was likely to face delays in sales pending FDA approval for additional indications.
* Outset Medical lacked the sales team and processes to manage the increasing demand for its Tablo products.

These alleged omissions, according to the lawsuit, led to a significant drop in Outset Medical’s revenue growth and ultimately, investor losses.

The Rosen Law Firm is now seeking lead plaintiffs to represent the class of investors in the lawsuit. Investors who purchased Outset Medical securities during the specified period may be entitled to compensation.

Interested parties can learn more about the class action lawsuit and how to join by visiting the Rosen Law Firm website or contacting the firm directly.

**About the Rosen Law Firm:**

The Rosen Law Firm is a leading global investor rights law firm with a proven track record of success in securities class action and shareholder derivative litigation. The firm has secured hundreds of millions of dollars in recoveries for investors.

**Disclaimer:**

This news article is for informational purposes only and should not be considered legal advice.

Read More